Aimee S Weisner's Net Worth
$9.01 Million
Who is Aimee S Weisner?
Aimee S Weisner has an estimated net worth of $9.01 Million. This is based on reported shares across multiple companies, which include Edwards Lifesciences Corp, ADVANCED MEDICAL OPTICS INC, GLAUKOS Corp, Oyster Point Pharma, Inc., LENSAR, Inc., and STAAR SURGICAL CO.
SEC CIK
Aimee S Weisner's CIK is 0001227308
Past Insider Trading and Trends
2023 was Aimee S Weisner's most active year for acquiring shares with 13 total transactions. Aimee S Weisner's most active month to acquire stocks was the month of April. 2009 was Aimee S Weisner's most active year for disposing of shares, totalling 11 transactions. Aimee S Weisner's most active month to dispose stocks was the month of January. 2024 saw Aimee S Weisner paying a total of $866,692.50 for 57,095 shares, this is the most they've acquired in one year. In 2024 Aimee S Weisner cashed out on 50,000 shares for a total of $3,000,000.00, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Edwards Lifesciences Corp (EW) Snapshot price: $66.81
CVP, General Counsel
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 9
| |||
Form 4
|
∞
| 1.68K |
—
|
—
| 1.68K |
May 12
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 10
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
ADVANCED MEDICAL OPTICS INC No price found
Executive Vice President
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -9.91K |
$22.00 | -$462,145.26 |
0
|
Feb 25 - Feb 26
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 29
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 11
| |||
Form 4
|
—
|
0
|
—
|
—
| 6.69K |
Apr 27 - May 21
| |||
Form 4
| -1.52% | -100.00 |
—
|
—
| 6.49K |
Feb 2 - Apr 27
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 6
| |||
Form 4
| +75.65% | 2.75K |
—
|
—
| 6.39K |
May 24
| |||
Form 4
|
—
|
0
|
$24.80 | -$387,154.58 | 3.39K |
Scheduled
|
Jul 26
| ||
Form 4
|
—
|
0
|
$23.53 | -$1,669,478.75 | 3.39K |
Scheduled
|
Jul 22
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 26
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 20
| |||
| No matching records found | |||||||||
GLAUKOS Corp (GKOS) Snapshot price: $129.28
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
$76.00 | -$2,200,000.00 | 30.12K |
Aug 8
| |||
Form 4
| +6.04% | 1.72K |
—
|
—
| 30.12K |
May 30
| |||
Form 4
| +3.25% | 895 |
—
|
—
| 28.4K |
Jan 2
| |||
Form 4
| +13.30% | 3.23K |
—
|
—
| 27.51K |
Jun 1
| |||
Form 4
| +41.19% | 10K |
$7.28 | $72,750.00 | 34.28K |
Mar 8
| |||
Form 4
| +6.92% | 1.57K |
—
|
—
| 24.28K |
Jan 3
| |||
Form 4
| +23.79% | 4.36K |
—
|
—
| 22.71K |
Jun 2
| |||
Form 4
| +8.62% | 1.46K |
—
|
—
| 18.34K |
Jan 3
| |||
Form 4
| +40.00% | 2K |
$51.66 | $103,320.00 | 7K |
Aug 9
| |||
Form 4
| +16.42% | 2.38K |
—
|
—
| 16.89K |
Jun 3
| |||
Form 4
| +7.25% | 980 |
—
|
—
| 14.51K |
Jan 4
| |||
Form 4
| +40.52% | 3.9K |
—
|
—
| 13.53K |
Jun 3
| |||
Form 4
| +13.73% | 1.16K |
—
|
—
| 9.63K |
Jan 2
| |||
Form 4
| +45.66% | 2.65K |
—
|
—
| 8.46K |
May 30
| |||
Form 4
| +25.40% | 1.18K |
—
|
—
| 5.81K |
Jan 2
| |||
Form 4
|
∞
| 4.63K |
—
|
—
| 4.63K |
May 31
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 13
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 2
| |||
Form 4
| +100.00% | 2.5K |
$16.03 | $40,075.00 | 5K |
Mar 4
| |||
Form 4
|
∞
| 2.5K |
$21.83 | $54,575.00 | 2.5K |
Nov 12
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 23
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Oyster Point Pharma, Inc. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -36.76K |
—
|
—
|
0
|
Jan 3
| |||
Form 4
| +10.76% | 3.57K |
—
|
—
| 36.76K |
Jun 6
| |||
Form 4
| +11.66% | 3.47K |
—
|
—
| 33.19K |
Jun 7
| |||
Form 4
| +28.54% | 6.6K |
—
|
—
| 29.73K |
Jun 8
| |||
Form 4
|
∞
| 23.13K |
—
|
—
| 23.13K |
Oct 31
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
LENSAR, Inc. (LNSR) Snapshot price: $4.9867
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +34.61% | 22K |
—
|
—
| 85.57K |
May 7
| |||
Form 4
| +17.11% | 9.29K |
—
|
—
| 63.57K |
May 25
| |||
Form 4
| +44.23% | 16.65K |
$2.75 | $45,779.25 | 54.28K |
May 22
| |||
Form 4
| +778.37% | 33.35K |
$2.56 | $85,488.27 | 37.64K |
May 17 - May 19
| |||
Form 4
|
∞
| 4.29K |
—
|
—
| 4.29K |
May 25
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 18
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 12
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 1
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||